Cooper Companies (COO) Cash from Financing Activities (2009 - 2026)
Cooper Companies' (COO) quarterly Cash from Financing Activities came in at -$75.8 million in Q2 2026, down 781.4% year-on-year from $11.1 million in Q2 2025, and up 48.75% quarter-over-quarter from -$147.9 million in Q1 2026.
Cooper Companies (COO) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Cooper Companies' Cash from Financing Activities history runs 18 years deep, the most recent figure standing at -$75.8 million for Q2 2026.
- On a quarterly basis, Cash from Financing Activities fell 781.4% year-over-year to -$75.8 million in Q2 2026; TTM through Apr 2026 was -$544.4 million, a 146.11% decrease from a year earlier, with the FY2025 full-year figure at -$425.9 million, down 1186.48% from the prior year.
- Cash from Financing Activities climbed to -$75.8 million in Q2 2026 per COO's latest filing, from -$147.9 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $1.7 billion in Q1 2022 and bottomed at -$368.7 million in Q3 2022.
- The 5-year median for Cash from Financing Activities is -$66.4 million (2024), against an average of $22.7 million.
- Across the five-year window, Cash from Financing Activities soared 12552.94% in 2022 and sank 1713.79% in 2023, its largest moves.
- Year by year, Cash from Financing Activities stood at -$134.1 million in 2022, then soared by 95.15% to -$6.5 million in 2023, then sank by 336.92% to -$28.4 million in 2024, then slumped by 478.87% to -$164.4 million in 2025, then surged by 53.89% to -$75.8 million in 2026.
- Per Business Quant, the three latest COO Cash from Financing Activities figures stand at -$75.8 million (Q2 2026), -$147.9 million (Q1 2026), and -$164.4 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -133.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -414.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | -13.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | -255.24 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -50.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | -48.13 Mn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | -11.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -75.80 Mn |
| Apr 30, 2026 | -75.80 Mn |
| Jan 31, 2026 | -147.90 Mn |
| Jan 31, 2026 | -147.90 Mn |
| Oct 31, 2025 | -164.40 Mn |
| Oct 31, 2025 | -164.40 Mn |
| Jul 31, 2025 | -156.30 Mn |
| Jul 31, 2025 | -156.30 Mn |
| Apr 30, 2025 | -8.60 Mn |
| Apr 30, 2025 | -8.60 Mn |
| Jan 31, 2025 | -96.60 Mn |
| Jan 31, 2025 | -96.60 Mn |
| Oct 31, 2024 | -28.40 Mn |
| Oct 31, 2024 | -28.40 Mn |
| Jul 31, 2024 | -87.60 Mn |
| Jul 31, 2024 | -87.60 Mn |
| Apr 30, 2024 | -57.10 Mn |
| Apr 30, 2024 | -57.10 Mn |
| Jan 31, 2024 | 212.30 Mn |
| Jan 31, 2024 | 212.30 Mn |